Norma Hernández-Pedro

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Signaling Pathway

Prostate Cancer

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Enrique Caballé-Perez, Norma Hernández-Pedro, Maritza Ramos-Ramírez, Pedro Barrios-Bernal, Eunice Romero-Nuñez, José Lucio-Lozada, Santiago Avila-Ríos, Gustavo Reyes-Terán, Andrés Felipe Cardona, Arrieta Oscar
Impact of KRAS G12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Norma Hernández-Pedro, Marisol Arroyo-Hernández, Pedro Barrios-Bernal, Eunice Romero-Nuñez, Victor Andrés Sosa-Hernández, Santiago Ávila-Ríos, José Luis Maravillas-Montero, Rogelio Pérez-Padilla, Diego de Miguel Pérez, Christian Rolfo, Arrieta Oscar
Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer. Vaccines 11 (10) (2023)
Pedro Barrios-Bernal, Zyanya Lucia Zatarain-Barrón, Norma Hernández-Pedro, Mario Orozco-Morales, Alejandra Olivera-Ramírez, Federico Ávila-Moreno, Ana Laura Colín-González, Andrés F Cardona, Rafael Rosell, Arrieta Oscar
Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)